Dan Meyer

Daniel Meyer is the CEO of CellChorus, the leader in providing dynamic single-cell functional analysis to the life sciences industry. Dan was the Chief Operating Officer and a board member of Genospace until its acquisition by HCA Healthcare (NYSE:HCA). He was a member of the venture capital investment teams at Arboretum Ventures and PJC.vc. Dan holds a B.A. in mathematics and economics from Middlebury College and an M.B.A. from the Tuck School of Business at Dartmouth.